You are here: Welcome » Scott Klarenbach

Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revisionPrevious revision
Next revision		Previous revision
Both sides next revision
scott_klarenbach [2022/10/25 07:16]
liam [Research] 		scott_klarenbach [2022/10/26 23:16] (current)
liam
Line 3: Line 3:
 {{ ::scottklarenbach.jpeg?200|}} {{ ::scottklarenbach.jpeg?200|}}
  
-Dr. **Scott Klarenbach**, MD, MSc, FRCPC is a Canadian nephrologist.+Dr. **Scott Klarenbach**, MD, MSc, FRCPC is a Canadian nephrologist. He is co-chair of the [[AHS COVID-19 Scientific Advisory Group]] under [[Alberta Health Services]].
  
 ===== Education ===== ===== Education =====
Line 24: Line 24:
 === Real-World Evidence Consortium === === Real-World Evidence Consortium ===
  
-Klarenbach is Director of the [[Real-World Evidence Consortium]] at the [[University of Calgary]], which conducts pharmacoepidemiologic and pharmacoeconomic research.((Klarenbach, S. (2022, May 12). //Disclosure Form.// Canadian Task Force on Preventative Health Care. https://web.archive.org/web/20221025043248/https://canadiantaskforce.ca/wp-content/uploads/2022/06/Disclosure-June2022-Klarenbach.pdf)) In his declaration of interest from June 2022, Klarenbach noted that the success of RWEC "is contingent on industry funding", though he doesn't receive any honoraria himself.+Klarenbach is Director of the [[Alberta Real-World Evidence Consortium]] at the [[University of Calgary]], which conducts pharmacoepidemiologic and pharmacoeconomic research.((Klarenbach, S. (2022, May 12). //Disclosure Form.// Canadian Task Force on Preventative Health Care. https://web.archive.org/web/20221025043248/https://canadiantaskforce.ca/wp-content/uploads/2022/06/Disclosure-June2022-Klarenbach.pdf)) In his declaration of interest from June 2022, Klarenbach noted that the success of RWEC "is contingent on industry funding", though he doesn't receive any honoraria himself.
  
 ==== Research ==== ==== Research ====
Line 30: Line 30:
 Klarenbach has published research funded by the [[Public Health Agency of Canada]] through the [[Jewish General Hospital]].((Beck, A., Persaud, N., Tessier, L. A., Grad, R., Kidd, M. R., Klarenbach, S., Korownyk, C., Moore, A., Thombs, B. D., Mangin, D., McCracken, R. K., McDonald, E. G., Sirois, C., Kanji, S., Molnar, F., Nicholls, S. G., Thavorn, K., Bennett, A., Shaver, N., & Skidmore, B. (2022). //Interventions to address potentially inappropriate prescriptions and over-the-counter medication use among adults 65 years and older in primary care settings: protocol for a systematic review.// Systematic Reviews, 11(1). https://doi.org/10.1186/s13643-022-02044-w)) Klarenbach has published research funded by the [[Public Health Agency of Canada]] through the [[Jewish General Hospital]].((Beck, A., Persaud, N., Tessier, L. A., Grad, R., Kidd, M. R., Klarenbach, S., Korownyk, C., Moore, A., Thombs, B. D., Mangin, D., McCracken, R. K., McDonald, E. G., Sirois, C., Kanji, S., Molnar, F., Nicholls, S. G., Thavorn, K., Bennett, A., Shaver, N., & Skidmore, B. (2022). //Interventions to address potentially inappropriate prescriptions and over-the-counter medication use among adults 65 years and older in primary care settings: protocol for a systematic review.// Systematic Reviews, 11(1). https://doi.org/10.1186/s13643-022-02044-w))
  
-Additional grants involving Klarenbach as Principal or co-Principal Investigator have come from:+Additional grants involving Klarenbach as Principal or co-Principal Investigator have come from:((//Profile | Dr. Scott Klarenbach.// University of Alberta. Retrieved October 25, 2022, from https://web.archive.org/web/20221025045508/https://www.ualberta.ca/medicine/about/people/details.html?n=scott-klarenbach#Grants))
  
   * [[Alberta Health Services]] (AHS)   * [[Alberta Health Services]] (AHS)
Back to top